Furthermore, arginine-methylated p53 is also found in breast cancer cells and the methylation signal of p53 can be weakened by silencing of PRMT1 with shRNA or inhibiting PRMT1 activity with a specific inhibitor. Here, PRMT1 is linked to breast cancer.